- Home
- ORC vs PLRX Comparison
ORC vs PLRX Comparison
Compare ORC & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORC
- PLRX
- Stock Information
- Founded
- ORC 2010
- PLRX 2015
- Country
- ORC United States
- PLRX United States
- Employees
- ORC N/A
- PLRX N/A
- Industry
- ORC Real Estate Investment Trusts
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- ORC Real Estate
- PLRX Health Care
- Exchange
- ORC Nasdaq
- PLRX Nasdaq
- Market Cap
- ORC 611.8M
- PLRX 641.5M
- IPO Year
- ORC 2013
- PLRX 2020
- Fundamental
- Price
- ORC $8.04
- PLRX $14.45
- Analyst Decision
- ORC Buy
- PLRX Strong Buy
- Analyst Count
- ORC 2
- PLRX 7
- Target Price
- ORC $9.50
- PLRX $40.50
- AVG Volume (30 Days)
- ORC 1.6M
- PLRX 459.1K
- Earning Date
- ORC 01-30-2025
- PLRX 11-07-2024
- Dividend Yield
- ORC 18.02%
- PLRX N/A
- EPS Growth
- ORC N/A
- PLRX N/A
- EPS
- ORC 1.01
- PLRX N/A
- Revenue
- ORC $75,695,000.00
- PLRX N/A
- Revenue This Year
- ORC N/A
- PLRX N/A
- Revenue Next Year
- ORC N/A
- PLRX N/A
- P/E Ratio
- ORC $7.91
- PLRX N/A
- Revenue Growth
- ORC N/A
- PLRX N/A
- 52 Week Low
- ORC $7.41
- PLRX $10.22
- 52 Week High
- ORC $9.08
- PLRX $19.62
- Technical
- Relative Strength Index (RSI)
- ORC 56.84
- PLRX 56.15
- Support Level
- ORC $8.01
- PLRX $13.14
- Resistance Level
- ORC $8.21
- PLRX $15.27
- Average True Range (ATR)
- ORC 0.12
- PLRX 0.75
- MACD
- ORC 0.01
- PLRX 0.00
- Stochastic Oscillator
- ORC 64.53
- PLRX 58.27
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.